KR7491000006
KR7491000006
LivsMed
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 |
|---|---|---|
Market & Enterprise Value | ||
Market Cap | 937.66B EUR | 921.31B EUR |
Enterprise Value | 886.76B EUR | 884.45B EUR |
Valuation Multiples | ||
Trailing P/E | -- | -- |
Forward P/E | -- | -- |
Price to Sales | 17.75x | 20.98x |
Price to Book | -- | 5.62x |
EV/Revenue | 16.79x | 20.14x |
EV/EBITDA | -32.4x | -- |
Price to FCF (P/FCF) | -- | -- |
EV/FCF | -- | -- |
FCF Yield | -7.14% | -9.5% |